Society News

Landmark decision will preserve access to care for people with pre-existing conditions, chronic disease The Endocrine Society today praised the U.S. Supreme Court’s decision to uphold the Affordable Care Act, which makes health care accessible to millions of individuals nationwide, including those with hormone health conditions such as diabetes, osteoporosis, thyroid conditions, and breast and prostate cancer....

The Endocrine Society appointed two new editors-in-chief of its prestigious journals. Ashley Grossman MD, FRCP, of Barts and the London School of Medicine in London, U.K., has been named the next editor-in-chief of Endocrine Reviews, and Zeynep Madak-Erdogan, PhD, of the University of Illinois at Urbana-Champaign in Urbana, Ill., has been named editor-in-chief of the...

By joining with the American Academy of Family Physicians, the American Association of Nurse Practitioners, and the American Academy of Physician Assistants, the Endocrine Society has created an educational coalition to address the challenges of treating patients with both type 2 diabetes and cardiovascular disease.   Together with the American Academy of Family Physicians (AAFP),...

While most organizations would have found 2020 a challenging year, the Endocrine Society’s Adrenal and Pituitary Special Interest Group managed to thrive with the help of new technology, expert staff guidance, and a group of determined members.   The Endocrine Society’s Adrenal and Pituitary Special Interest Group (AP-SIG) was created to connect physicians and scientists...

Applauds reintroduction of H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act to improve access to affordable medications The Endocrine Society is calling on Congress to pass legislation to lower the price of insulin and applauds the efforts of Energy and Commerce Committee Chairman Frank Pallone Jr. (D-NJ), Ways and Means Committee Chairman...